CryoLife Picks Up Genesee BioMedicals’ PhotoFix Patch April 14, 2016 The patch realized $1.4 million in sales last year. Read More
EMA Establishes Standards for Producing Unique Identifiers for Drugs April 14, 2016 Drugmakers selling into the EU will have two years to comply with new standards. Read More
FDA Panel to Review St. Jude’s Amplatzer Cardiac Implant April 13, 2016 The device is indicated to treat an atrial septal defect. Read More
Heptares, Allergan Ink Exclusive Licensing Agreement April 13, 2016 Allergan will gain the rights to drugs targeting neurological disorders. Read More
Halyard Health to Acquire Corpak MedSystems April 12, 2016 Corpak generated $54 million in sales for fiscal 2015. Read More
Court Nixes Lawsuits Alleging Zoloft, Birth Defect Connection April 12, 2016 Pfizer was accused of failing to warn about possible birth defects linked to Zoloft. Read More
Bioness Launches Bioness Intergrated Therapy System 2.0 April 11, 2016 The reports module provides personalized therapy programs. Read More
Type 2 Diabetes Drugs Linked to Heart Problems April 11, 2016 Clinical trials found that drugs containing saxagliptin and alogliptin were linked to heart failure. Read More
Abiomed’s Impella Therapy Snaps Up Premarket Approval April 8, 2016 The pumps are intended for short-term treatment of ongoing cardiogenic shock. Read More
Gilead Enters Agreement to Acquire Nimbus Apollo for $1.2B April 8, 2016 Gilead will pay Nimbus $400 million upfront, under the agreement. Read More
St. Jude Introduces Trifecta Valve in EU April 7, 2016 The valve received CE marking in February. Read More
Pfizer’s Bococizumab Yields Positive Results in Phase 3 April 7, 2016 The candidate met its endpoints of reducing low-density lipoprotein cholesterol at 12 weeks. Read More